ID

13236

Beschreibung

A Safety Study of SGN-CD33A in AML Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01902329

Link

https://clinicaltrials.gov/show/NCT01902329

Stichworte

  1. 25.01.16 25.01.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

25. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Acute Myelogenous Leukemia NCT01902329

Eligibility Acute Myelogenous Leukemia NCT01902329

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
acute myeloid leukemia, positive for cd33
Beschreibung

AML

Datentyp

boolean

Alias
UMLS CUI [1]
C0023467
eastern cooperative oncology group status of 0 or 1
Beschreibung

ECOG

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
adequate baseline renal and hepatic function
Beschreibung

renal and hepatic function

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0232804
UMLS CUI [1,2]
C0232741
central venous access
Beschreibung

central venous access

Datentyp

boolean

Alias
UMLS CUI [1]
C1145640
either achieved complete remission (greater than 12 weeks in duration) with initial induction/consolidation and have experienced relapse of disease or declined treatment with high-dose induction/consolidation
Beschreibung

remission or relapse

Datentyp

boolean

Alias
UMLS CUI [1]
C0544452
UMLS CUI [2]
C0277556
bone marrow blasts greater than or equal to 5% for relapsed patients, or greater than or equal to 20% for untreated patients
Beschreibung

bone marrow blasts

Datentyp

boolean

Alias
UMLS CUI [1]
C0368761
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
inadequate lung function
Beschreibung

pulmonary function

Datentyp

boolean

Alias
UMLS CUI [1]
C0231921
prior allogeneic stem cell transplant, except for a specific cohort
Beschreibung

stem cell transplant

Datentyp

boolean

Alias
UMLS CUI [1]
C1504389
high-dose chemotherapy within 4 weeks of study drug
Beschreibung

chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
antileukemia treatment within 14 days of study drug (other than hydroxyurea or 6-mercaptopurine)
Beschreibung

antileukemia treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111

Ähnliche Modelle

Eligibility Acute Myelogenous Leukemia NCT01902329

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
AML
Item
acute myeloid leukemia, positive for cd33
boolean
C0023467 (UMLS CUI [1])
ECOG
Item
eastern cooperative oncology group status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
renal and hepatic function
Item
adequate baseline renal and hepatic function
boolean
C0232804 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
central venous access
Item
central venous access
boolean
C1145640 (UMLS CUI [1])
remission or relapse
Item
either achieved complete remission (greater than 12 weeks in duration) with initial induction/consolidation and have experienced relapse of disease or declined treatment with high-dose induction/consolidation
boolean
C0544452 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
bone marrow blasts
Item
bone marrow blasts greater than or equal to 5% for relapsed patients, or greater than or equal to 20% for untreated patients
boolean
C0368761 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pulmonary function
Item
inadequate lung function
boolean
C0231921 (UMLS CUI [1])
stem cell transplant
Item
prior allogeneic stem cell transplant, except for a specific cohort
boolean
C1504389 (UMLS CUI [1])
chemotherapy
Item
high-dose chemotherapy within 4 weeks of study drug
boolean
C0392920 (UMLS CUI [1])
antileukemia treatment
Item
antileukemia treatment within 14 days of study drug (other than hydroxyurea or 6-mercaptopurine)
boolean
C0087111 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video